Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal

The Tampa Bay Business Journal recognized Patricia Lawman, founder and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company  Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, for being part of the region’s top health care innovators. The feature was part of the Florida Business Journal’s statewide Future of Health Care […]

Patricia Lawman Develops Novel Cell and Gene Therapies to Fight Cancer

Patricia Lawman is on a mission to change the future of cancer care. After losing her parents to lung cancer and lymphoma, respectively, she recognized the detrimental impact of radiation and chemotherapy. She knew there must be a way to treat a patient’s cancer without the risk of toxicity and other negative side effects. After […]

Bioscience Firm Makes Progress on Another Kind of Vaccine

The word vaccine carries heavy weight these days, with its tantalizing possibilities to curb the destruction brought on by a certain C-word. But for UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, the word vaccine is connected to a different kind of C-word: cancer. […]

Morphogenis and USF Health Form Clinical Research Partnership

USF Health has partnered with UF startup and UF Innovate | Sid Martin Biotech alumn Morphogenesis, Inc., a biotechnology company developing immunotherapies for cancer patients, on a two-year contract that runs the gamut. The affiliation agreement will allow for clinical and clinical research collaborations, opportunities for students to intern for Morphogenesis, and the company will […]

Morphogenesis Seeks Skin Cancer Patients for New Clinical Trials

Known for developing personalized immunotherapies for the treatment of cancer through novel cell and gene therapies, UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., has received FDA approval to expand its human clinical trials into two more types of cancer. Using its ImmuneFx (IFx) cancer vaccine technology that initiates the power […]

ImmuneFX Gene Therapy Could Be a Game-Changer for Cancer Treatment

UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage company that develops novel cell and gene therapies based out of Tampa, recently got FDA approval to expand human clinical trials with an innovative cancer vaccine. Grit Daily interviewed Morphogenesis CEO Dr. Patricia Lawman to get more information about this technology that could […]

Clinical Trial for ‘Promising’ Gene-therapy Treatment for Cancer Is Unveiled

Is it finally possible that an effective, minimally invasive, cost-efficient treatment for cancer is on the horizon? UF startup Morphogenesis Inc., a clinical-stage immunotherapy company headquartered in Tampa, has been developing cancer treatment since the 1990s. In January 2020, the company’s human clinical trials opened when the Food and Drug Administration enabled the expansion of its […]

Tampa Company Expands Clinical Trials of Cancer Vaccine

UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, is moving forward with clinical trials of a cancer vaccine after getting FDA approval.  The company developed the vaccine after decades of research and study. Earlier trials showed promise in larger animals afflicted with melanoma. Now […]

Cancer Research Company in Tampa Nears Breakthrough

A scientist on the verge of a breakthrough in the war on cancer is quietly working away with a team of researchers in a laboratory in the heart of Uptown Tampa’s innovation district.  UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage company developing novel cell and gene therapies, is […]